Press Releases

Email Alerts

May 9, 2017

Dr. Christine Finck of Connecticut Children's Medical Center, Presents Data in Poster Presentation from Collaboration with Biostage at the American Pediatric Surgical Association (APSA) 2017 Annual Meeting

- Dr. Finck's Presentation Awarded Best Poster in Basic Science at APSA

Biostage, Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
May 5, 2017

Biostage to Host 2017 First Quarter Update Conference Call

- Conference Call with Live Audio Webcast on Thursday, May 11th at 9:00 AM ET -

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
May 1, 2017

Biostage to Present at the American Association for Thoracic Surgery Centennial Meeting

- Biostage to present on Monday, May 1 at 3:25 p.m. EDT -

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
Apr 26, 2017

Biostage to Participate at the Alliance for Regenerative Medicine's 5th Annual Cell & Gene Therapy Investor Day

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
Apr 18, 2017

Biostage Appoints Stephen F. Badylak DVM, PhD, MD, as Co-Chairman of Scientific Advisory Board

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and...

Show per page